Lanean...
Study of Three Cases of Primary Refractory T Cell ALL
A significant proportion of T cell acute lymphoblastic leukemia (T-ALL) patients do not achieve complete remission after 4 weeks of induction chemotherapy or relapse early. Salvage chemotherapy for such patients usually results in poor outcome which can be up to 20–30% survival with allogeneic BMT....
Gorde:
| Argitaratua izan da: | Indian J Hematol Blood Transfus |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer India
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8239107/ https://ncbi.nlm.nih.gov/pubmed/34267473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01392-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|